Four stocks reached the daily price-limit range today. Some have a clear catalyst; others still carry a question mark. Two newly listed stocks rose more than 60%, but their first-day price limits differ and are excluded here.
【테라뷰 · 950250】 4,355원 (+30.00%) Signed a KRW 1.36146 billion inspection-equipment contract with Covalent Metrology, equal to 17.39% of recent annual sales.
【씨싸이트 · 109670】 16,730원 (+29.99%) A KRW 50.4 billion deal for a 74.94% stake and management control involving former Ourhome chair Koo Mi-hyun and five others drew attention.
【라메디텍 · 462510】 4,035원 (+29.95%) No directly linked new disclosure was found that day. Foreign net buying was reported, but cannot be established as the sole cause.
【현대바이오랜드 · 052260】 5,670원 (+29.90%) No direct same-day catalyst was verified. Improved first-half results are a possible background, not a proven cause of the price jump. 【Snapshot】Sep 29, 2026, 16:21 KST during extended KRX trading; not the final 20:00 close. Prices may change. 【Sources】Npay rising-stock ranking: https://stock.naver.com/market/stock/kr/stocklist/upper Teraview filing: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260928900230 Seasight filing: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260923900730 Lameditech flow report: https://www.newspim.com/news/view/20260929000359 Hyundai Bioland earnings report: https://www.digitaltoday.co.kr/news/articleView.html?idxno=689349 This is not investment advice.